United Kingdom-based GW Pharmaceuticals showed revenue of $39.2 million for the quarter ended March 31, 2019, compared with $3 million in the same period a year ago.
Nick Thomas
Nick Thomas's Latest Posts
Multistate marijuana firm Curaleaf to expand into Ohio with $20 million acquisition
Massachusetts-based Curaleaf, which last week agreed to acquire Cura Partners for almost $1 billion, will expand into Ohio with the purchase of Ohio Grown Therapies. The $20 million deal, expected to close in the second half of 2019, includes...
Weekly Deal Watch: Lower volume but larger raises dominate marijuana capital
The number of cannabis capital raises may be slightly down so far in 2019 over the previous year, but the amount of money raised is almost double.
Investor Watch: MedMen fumbles are putting investors on fence
When California-based cannabis company MedMen released its most recent financial results Feb. 28, CEO Adam Bierman acknowledged the group had not done enough to “own our own narrative.”
Cannabis group Curaleaf to acquire Cura Partners for CA$1.27 billion
Massachusetts-based Curaleaf, a vertically integrated cannabis company, agreed to acquire Portland, Oregon-based Cura Partners in an all-stock deal worth 1.27 billion Canadian dollars ($949 million). Curaleaf will issue 95.6 million subordinated voting shares, giving...
Q4 revenue jumps 72% for cannabis group Vireo amid state expansion
Vireo Health International, the Minneapolis-based, vertically integrated marijuana firm, reported revenue of $5.6 million for the fourth quarter of 2018, up 72% from the same period the prior year. Net loss for the quarter totaled $1.2 million versus profit of just...
High Times parent to close share offering; cannabis publication still eyes Nasdaq
The parent of the iconic cannabis magazine High Times will close its share offering by June 30, executive chairman Adam Levin told Marijuana Business Daily.
Green Growth offer for Aphria cannabis group expires
Ohio-based marijuana group Green Growth Industries' offer for Canadian producer Aphria has expired, ending the hostile takeover bid. Aphria, which trades as APHA on both the New York Stock Exchange and the Toronto Stock Exchange, consistently...
BNY Mellon involved in new marijuana NYSE fund
Bank of NY Mellon will act as custodian bank to a new cannabis-focused exchange-traded fund (ETF), the first time a New York Stock Exchange marijuana-related fund has seen backing by a major bank. The AdvisorShares Pure Cannabis ETF, which...
Sol Global to acquire Michigan cannabis group MCP Wellness for $150 million
Sol Global, a Toronto-based investment company focused on the cannabis industry, agreed to acquire Michigan-based MCP Wellness, which has licenses to operate retail and cultivation centers in the state. The acquisition of MCP Wellness, which...
Cannabis vaporizer company Pax Labs raises benchmark $420 million in funding
Pax Labs, a San Francisco-based maker of vaporizers, confirmed it raised $420 million in equity financing, a record for a U.S.-based marijuana company. The firm said the round included both new and existing institutional investors, including New York-based Tiger...
Acreage to buy Nevada cannabis company Deep Roots for $120 million
On the same day it announced it was being acquired by Canada's Canopy Growth in a groundbreaking deal, New York-based marijuana firm Acreage Holdings unveiled it is buying Deep Roots, a vertically integrated cannabis company based in Nevada. The $120 million deal was...
